Advanced manufacturing innovations boost IperionX’s titanium production capabilities

268
IperionX’s titanium production facility, Virginia. Image credit: IPerionX

IperionX has reported advancements for the quarter ending 31 December 2024, highlighted by the completion of its inaugural “end-to-end” titanium metal powder production using the proprietary HAMR process. 

This advancement at its Titanium Manufacturing Campus in Virginia marks a crucial step in leveraging high-oxygen titanium scrap to produce low-oxygen, high-quality titanium metal powder.

The company also made strides in manufacturing, commissioning a new 100-ton uniaxial hydraulic powder metallurgy press to meet increasing customer demand for high-value, near-net-shape titanium products. 

The adoption of its patented Hydrogen Sintering and Phase Transformation (HSPT) technology has enabled faster, cost-effective production of high-quality titanium products, circumventing traditional, resource-intensive methods.

In research and development, IperionX reconfigured its Salt Lake City Industrial Pilot Facility to focus on producing new alloys, including zirconium and refractory metals such as niobium and tantalum. 

Additionally, the company advanced its ARH and Green Rutile technologies, aimed at creating cost-effective, US-sourced titanium feedstocks.

A milestone acquisition was finalised during the quarter, consolidating IperionX’s intellectual property portfolio of titanium technologies. 

These technologies are positioned as transformative alternatives to the conventional Kroll process, offering enhanced energy efficiency, cost-effectiveness, and streamlined production cycles.

IperionX’s efforts are closely aligned with US government initiatives to bolster domestic titanium supply chains. 

The appointment of retired Lieutenant General Ross Coffman as Defense Advisor underscores the company’s strategic focus on catering to defence applications. 

The company continues to advance proposals for government funding, with opportunities under programs such as the DPA Title III and IBAS initiatives.

Financially, IperionX concluded a $66 million placement, strengthening its cash reserves to $77.1 million as of 31 December 2024. 

These funds will support ongoing expansions at its Virginia campus, with a focus on meeting customer production requirements by mid-2025.